NYSE · WST
West Pharmaceutical Services, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for WST has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.18 | $2.20 | $2.14 | 5 |
| Dec 2026 | $2.26 | $2.28 | $2.24 | 4 |
| Mar 2027 | $2.24 | $2.37 | $2.15 | 3 |
| Jun 2027 | $2.52 | $2.65 | $2.43 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews- Zacks · 9 h agoCompared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key MetricsAlthough the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- RTTNews · 11 h agoWest Pharmaceutical Services Q3 26 Earnings Conference Call At 8:00 AM ET(RTTNews) – West Pharmaceutical Services (WST) will host a conference call at 8:00 AM ET on October 29, 2026, to discuss Q3 26 earnings results.
- RTTNews · 11 h agoWest Pharmaceutical Services Raises Annual Outlook- Update(RTTNews) – West Pharmaceutical Services, Inc. (WST), a manufacturer of packaging and delivery systems for injectable drugs, Thursday raised its full-year outlook after reporting improved third-quarter results.
- Zacks · 11 h agoWest Pharmaceutical Services (WST) Q3 Earnings and Revenues Top EstimatesWest Pharmaceutical (WST) delivered earnings and revenue surprises of +22.02% and +5.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · 11 h agoWest Pharmaceutical Services Inc. Q3 Income Rises(RTTNews) – West Pharmaceutical Services Inc. (WST) released a profit for its third quarter that Increases, from last year
- Zacks · Oct 28, 8:15 AM EDTWest Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesGet a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
- Zacks · Oct 27, 8:39 AM EDTWST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.
- Zacks · Oct 21, 8:29 AM EDTReasons to Add West Pharmaceutical Stock to Your Portfolio NowWest Pharmaceutical???s biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.
- Zacks · Oct 15, 8:25 AM EDTWest Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?West Pharmaceutical shares have surged 36.1% YTD, fueled by strong demand for high-value components, earnings momentum and raised guidance. Can the rally continue?
- Zacks · Oct 13, 10:03 AM EDTVeeva Systems' Basics Gains Traction With 175+ Emerging Biotech FirmsVEEV's push into early-stage biotech could unlock long-term revenue opportunities as its streamlined software solutions simplify critical drug development processes.
- Zacks · Oct 9, 9:58 AM EDTANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/YAngioDynamics beats first-quarter earnings estimates as revenues rise 6.9% on strong Med Tech growth, with margin expansion and robust Auryon and NanoKnife sales.
- Zacks · Oct 9, 9:43 AM EDTReasons to Hold Veeva Systems Stock in Your Portfolio for NowVEEV's strong second-quarter results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for West Pharmaceutical Services, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.